ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Galderma Laboratories 

14501 N. Freeway

Fort Worth  Texas  76177  U.S.A.
Phone: 817-961-5000 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Galderma Laboratories Announces Positive Results Of Phase 3 Trials Of Investigational Ivermectin 1% Targeting Papulopustular Rosacea 3/24/2014 7:30:20 AM    More...
Bioventus Acquires DUROLANE® Assets From Galderma 2/4/2014 9:35:19 AM    More...
Galderma Laboratories Slashes U.S. Staff After President's Exit 12/13/2013 8:10:13 AM    More...
Onset Dermatologics (Formerly known as Onset Therapeutics) Acquires Worldwide Rights to Clindagel® (clindamycin phosphate gel) Topical Gel, 1% From Galderma Laboratories 10/31/2013 12:29:49 PM    More...
Galderma Laboratories Serves as Premier Sponsor for 2013 Commit to Cure Gala Benefitting National Psoriasis Foundation 10/21/2013 8:05:34 AM    More...
Galderma Laboratories Release: Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship 9/11/2013 9:27:51 AM    More...
Galderma Laboratories Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea 8/26/2013 6:57:46 AM    More...
New Retrospective Analysis on Galderma Laboratories’ Differin® Gel, 0.3% in Adult Female Acne Patients 8/1/2013 11:23:11 AM    More...
Galderma Laboratories Release: Epiduo® TAP Program May Increase Patient Adherence to Acne Treatment 3/12/2013 9:36:26 AM    More...
Galderma Laboratories Release: Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available for Children as Young as 9 Years Old 2/20/2013 9:25:00 AM    More...
12345